These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15763635

  • 1. Ketamine reduces cholinergic modulated GABA release from rat striatal slices.
    Grasshoff C, Gillessen T, Wagner E, Thiermann H, Szinicz L.
    Toxicol Lett; 2005 Apr 28; 156(3):361-7. PubMed ID: 15763635
    [Abstract] [Full Text] [Related]

  • 2. [Ketamine inhibits n-methyl-d-aspartate (NMDA) receptor mediated acetylcholine release from rabbit caudate nucleus slices].
    Feuerstein TJ.
    Anaesthesist; 1994 Nov 28; 43 Suppl 2():S48-51. PubMed ID: 7840414
    [Abstract] [Full Text] [Related]

  • 3. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
    Hamrouni AM, Gudka N, Broadley KJ.
    Auton Autacoid Pharmacol; 2006 Jul 28; 26(3):275-84. PubMed ID: 16879493
    [Abstract] [Full Text] [Related]

  • 4. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B, Gil-Bea FJ, Hirst WD, García-Alloza M, Ramírez MJ.
    Eur J Neurosci; 2006 Sep 28; 24(5):1299-306. PubMed ID: 16987217
    [Abstract] [Full Text] [Related]

  • 5. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C, Weiss M, Rostain JC.
    Brain Res; 2007 Oct 24; 1176():37-44. PubMed ID: 17900538
    [Abstract] [Full Text] [Related]

  • 6. Ketamine induces hyperactivity in rats and hypersensitivity to nicotine in rat striatal slices.
    Rodvelt KR, Kracke GR, Schachtman TR, Miller DK.
    Pharmacol Biochem Behav; 2008 Nov 24; 91(1):71-6. PubMed ID: 18639577
    [Abstract] [Full Text] [Related]

  • 7. Effect of MK-801 on dopamine release evoked by hypoxia combined with hypoglycemia.
    Milusheva E.
    Acta Physiol Hung; 1992 Nov 24; 79(4):347-54. PubMed ID: 1343187
    [Abstract] [Full Text] [Related]

  • 8. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM, Kreipke CW, Walker PD.
    Neuroscience; 2006 Nov 24; 137(2):505-17. PubMed ID: 16289829
    [Abstract] [Full Text] [Related]

  • 9. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M, Marti M, Auberson YP, Morari M.
    J Neurochem; 2007 Dec 24; 103(6):2200-11. PubMed ID: 17986236
    [Abstract] [Full Text] [Related]

  • 10. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
    Adams BW, Bradberry CW, Moghaddam B.
    Synapse; 2002 Jan 24; 43(1):12-8. PubMed ID: 11746729
    [Abstract] [Full Text] [Related]

  • 11. Endogenous GABA release from rat striatal slices: effects of the GABAB receptor antagonist 2-hydroxy-saclofen.
    Mayfield RD, Zahniser NR.
    Synapse; 1993 May 24; 14(1):16-23. PubMed ID: 8390105
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats.
    Antoniou K, Kehr J, Snitt K, Ogren SO.
    Br J Pharmacol; 1997 Jul 24; 121(6):1180-6. PubMed ID: 9249255
    [Abstract] [Full Text] [Related]

  • 13. 3-Nitropropionic acid exacerbates [3H]GABA release evoked by glucose deprivation in rat striatal slices.
    Boireau A, Meunier M, Doble A.
    J Pharm Pharmacol; 1996 Jan 24; 48(1):85-9. PubMed ID: 8722502
    [Abstract] [Full Text] [Related]

  • 14. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.
    Pinault D.
    Biol Psychiatry; 2008 Apr 15; 63(8):730-5. PubMed ID: 18022604
    [Abstract] [Full Text] [Related]

  • 15. AMPA and NMDA receptor regulation of firing activity in 5-HT neurons of the dorsal and median raphe nuclei.
    Gartside SE, Cole AJ, Williams AP, McQuade R, Judge SJ.
    Eur J Neurosci; 2007 May 15; 25(10):3001-8. PubMed ID: 17509083
    [Abstract] [Full Text] [Related]

  • 16. Interaction between M1-muscarinic and glutamatergic NMDA receptors on an inhibitory avoidance task.
    Monteiro Moreira K, Lima Ferreira T, Vecchio Fornari R, Perez Figueredo LZ, Menezes Oliveira MG.
    Brain Res Bull; 2005 Nov 30; 67(6):504-8. PubMed ID: 16216700
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 18. NMDA receptor blockade augmented nicotine-evoked dopamine release from rat prefrontal cortex slices.
    Rodvelt KR, Schachtman TR, Kracke GR, Miller DK.
    Neurosci Lett; 2008 Aug 08; 440(3):319-22. PubMed ID: 18579301
    [Abstract] [Full Text] [Related]

  • 19. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis.
    Smolders I, Bogaert L, Ebinger G, Michotte Y.
    J Neurochem; 1997 May 08; 68(5):1942-8. PubMed ID: 9109520
    [Abstract] [Full Text] [Related]

  • 20. The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression.
    Wirtshafter D.
    Brain Res; 2006 Apr 26; 1085(1):127-31. PubMed ID: 16564505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.